Hydrogen sulfide: A new EDRF

153Citations
Citations of this article
89Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The first endothelium-derived relaxing factor (EDRF) ever identified is a gasotransmitter, nitric oxide (NO). Recent studies have provided several lines of evidence to support the premise that hydrogen sulfide (H 2 S), another gasotransmitter, is a new EDRF. H 2 S production is catalyzed in mammalian cells by cystathionine Β-synthase (CBS) and/or cystathionine γ-lyase (CSE). The expression of CSE proteins and the activity of CBS have been observed in vascular endothelial cells. A measurable amount of H 2 S is produced from endothelium upon muscarinic cholinergic stimulation. The endothelium-dependent vasorelaxation induced by H 2 S shares many common mechanistic traits with those of endothelium-derived hyperpolarizing factor (EDHF). Deficiency in CSE expression increases blood pressure in CSE knockout mice and significantly diminishes endothelium-dependent relaxation of resistance arteries. More extensive and mechanistic studies in the future will help to determine whether H 2 S is a new EDRF or the very EDHF. © 2009 Inernational Society of Nephrology.

Cite

CITATION STYLE

APA

Wang, R. (2009). Hydrogen sulfide: A new EDRF. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2009.221

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free